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Autophagy isacellular lysosome-dependentcatabolic
mechanism mediating the turnover of intracellular
organelles and long-lived proteins. We show that anti-
mycin A, a known inhibitor of mETC complex III, can
inhibit autophagy. A structural and functional study
shows that four close analogs of antimycin A that
have no effect on mitochondria inhibition also do not
inhibit autophagy, whereas myxothiazol, another
mETC complex III inhibitor with unrelated structure
to antimycin A, inhibits autophagy. Additionally, anti-
mycin A and myxothiazol cannot inhibit autophagy in
mtDNA-depleted H4 andmtDNA-depleted HeLa cells.
These data suggest that antimycin A inhibits auto-
phagy through its inhibitory activity onmETCcomplex
III. Our data suggest that mETC complex III may have
a role in mediating autophagy induction.
INTRODUCTION
Autophagy is a cellular lysosome-dependent catabolic mecha-
nism mediating the turnover of intracellular organelles and
long-lived proteins (Baehrecke, 2005; Codogno and Meijer,
2005; Klionsky et al., 2008; Levine and Klionsky, 2004; Levine
and Yuan, 2005). Autophagy plays a very important role in normal
development and is involved in multiple human diseases,
including bacterial and viral infections, neurodegenerative disor-
ders, cardiovascular disease, acute pancreatitis, cancer, aging,
obesity, and type II diabetes (Goldman et al., 2010; Hashimoto
et al., 2008; Helin et al., 1980; Jin and White, 2008; Shintani
and Klionsky, 2004; Zhang et al., 2009). The formation of auto-
phagosomes is mediated by a set of approximately 30 ATG
genes that were first identified in yeast Saccharomyces cerevi-
siae and, subsequently, found to be conserved during evolution,
including in mammals (Cao and Klionsky, 2007; Klionsky et al.,
2003; Levine and Klionsky, 2004; Reggiori and Klionsky, 2002).
The mitochondrion is known to play an important role in inte-
grating signals regulating cell survival. Recently, the outer
membrane of mitochondria in mammalian cells has been sug-
gested as a new source of autophagosomal membranes under1474 Chemistry & Biology 18, 1474–1481, November 23, 2011 ª2011starvation conditions (Hailey et al., 2010; McEwan and Dikic,
2010), but the detailed mechanism is unclear.
Antimycin A (AMA) is a chemical compound produced by
Streptomyces kitazawensis (Nakayama et al., 1956). AMA is
known to bind to the Qi site of cytochrome c reductase in the mi-
tochondrial complex III to inhibit the oxidation of ubiquinol in the
electron transport chain, which blocks themitochondrial electron
transfer between cytochrome b and c (Alexandre and Lehninger,
1984; Campo et al., 1992; Maguire et al., 1992; Pham et al.,
2000; Xia et al., 1997). The inhibition of electron transport causes
a collapse of the proton gradient across the mitochondrial inner
membrane, leading to the loss of the mitochondrial membrane
potential (DJm) (Balaban et al., 2005; Campo et al., 1992; Pham
et al., 2000). The consequences of inhibiting complex III include
an increase in theproductionofROS (Balabanetal., 2005;Panduri
et al., 2004) and a reduction in the cellular levels of ATP (Campo
et al., 1992; Maguire et al., 1992; Pham et al., 2000).
In this study we identified an unexpected activity of mitochon-
drial electron transport chain (mETC) complex III inhibitor AMA in
inhibiting autophagy. Using AMA as a tool, we explored the role
of mitochondria in mediating autophagy. Our results suggest
that mETC complex III may have a role in mediating autophagy.
RESULTS
AMA Inhibits Autophagy
To explore the potential role of mitochondria in regulating auto-
phagy, we used AMA, the mETC complex III inhibitor, to treat
a human glioblastoma H4 cell stably expressing LC3-GFP (Sar-
kar et al., 2007; Zhang et al., 2007). The treatment of AMA in-
hibited the increase in the levels of autophagosomes induced
by rapamycin, as indicated by the LC3-GFP+ puncta (Figure 1A).
Imaging analysis showed that AMA significantly reduced the
number of LC3-GFP+ puncta (Figure 1A). Similarly, the treatment
of AMA reduced both basal and rapamycin-induced autophagy
in MEF cells (Figure 1B), and serum starvation induced auto-
phagy in HeLa cells (Figure 1C). Furthermore, the inhibition of
autophagy by AMA was dose and time dependent (Figures 1D
and 1E). AMA began to inhibit autophagy at 5 ng/ml (9.5 nM),
and inhibited autophagy obviously after 2 hr treatment at
10 ng/ml in MEF cells. AMA also inhibited autophagy in Bcap-
37 cells (see Figure S1A available online), which indicated that
AMA effect is not cell specific.Elsevier Ltd All rights reserved
Figure 1. AMA Inhibits Autophagy
(A) The effect of AMA on rapamycin (Rap)-induced autophagy in H4-LC3-GFP cells. H4-LC3-GFP cells were treated with AMA (10 ng/ml) in the presence or
absence of Rap (0.2 mM) for 6 hr, and the images were collected and analyzed with a HCS Reader.
(B and C) The effect of AMA on the levels of LC3II. (B) MEF cells were treated with AMA (10 ng/ml) in the presence or absence of Rap (0.2 mM) for 8 hr, and the cell
lysates were subjected to western blotting using anti-LC3 antibody. Anti-a-tubulin was used as a loading control. (C) HeLa cells were treated with AMA (10 ng/ml)
with or without serum starvation for indicated times, and the cell lysates were subjected to western blotting using anti-LC3 antibody. Anti-a-tubulin was used as
a loading control.
(D) The dose effect of AMA on the levels of LC3II. MEF cells were treated with AMA at different concentrations for 6 hr, and the cell lysates were subjected to
western blotting using anti-LC3 and anti-a-tubulin antibodies.
(E) The effect of AMA on the levels of LC3II. MEF cells were treated with indicated compounds for different times, and the cell lysates were subjected to western
blotting using anti-LC3 and anti-a-tubulin antibodies.
(F) The effect of AMA on the levels of LC3II induced by E-64d. H4 cells were treated by indicated compounds for 4 hr, and the cell lysates were subjected to
western blotting using anti-LC3 and anti-a-tubulin antibodies.
See also Figure S1.
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(Tanida et al., 2005). Consistently, the treatment of AMA also
reduced the levels of LC3II in the presence of E-64d, which
blocks the lysosomal degradation (Figure 1F). Taken together,
these results indicate that AMA can inhibit autophagy in
mammalian cells.
AMA-Mediated Inhibition of Autophagy Is Independent
of ATP and ROS Reduction
AMA specifically inhibits mitochondrial electron transport
between cytochrome b and c, which leads to a loss of intracel-Chemistry & Biology 18, 1474–148lular ATP (Campo et al., 1992; Maguire et al., 1992; Pham
et al., 2000). Because autophagy pathway contains several
energy-dependent steps (Plomp et al., 1989), one might postu-
late that a reduction in the levels of ATP induced by AMA may
lead to autophagy inhibition. To test this possibility, we deter-
mined whether ATP reduction induced by AMA contributes to
autophagy inhibition. We tested the effects of a glycolytic inhib-
itor 2-deoxy-D-glucose (2DG) (Dennis et al., 2001), which inhibits
glycolysis, and AICAR, which activates AMPK (Meley et al.,
2006), on autophagy in MEF cells (Liang et al., 2007). The treat-
ment of MEF cells with 2DG significantly reduced the levels1, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1475
Figure 2. AMA-Mediated Inhibition of Autophagy Is Independent of
ATP and ROS Reduction
(A) The effect of 2DG and AMA on ATP and autophagy. MEF cells were treated
for 8 hr with 2DG or AMA at indicated concentrations, and the cell lysates were
subjected to ATP assay or western blotting using anti-LC3 and anti-a-tubulin
antibodies.
(B) The effect of AICAR on AMA reduced ATP and autophagy. MEF cells were
pretreated for 1 hr with the AMPK activator AICAR (0.5 mM), and then treated
with AICAR for another 4 hr in the presence or absence of AMA (5 ng/ml), and
the cell lysates were subjected to ATP assay or western blotting using anti-LC3
and anti-a-tubulin antibodies.
(C) The effect of AMA on ROS generation. H4 or MEF cells were treated with
AMA at indicated concentrations for 2 hr before incubating with DHE (1 mg/ml)
for 20 min; the fluorescent images were then collected and analyzed with
a HCS Reader.
See also Figure S2.
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inhibited autophagy at 10 ng/ml, which had a lesser effect on
ATP than that of glycolytic inhibitor 2DG (Figure 2A). The result
indicated thatAMA inhibitionofautophagywasnotdue toa reduc-
tion in the levels of ATP. Additionally, we found that the treatment
of MEF cells with AMA at 5 ng/ml for 8 hr, which was sufficient to
inhibit autophagy (Figure 1D), had aminimumeffect on the cellular
levels of ATP at this time point (Figure 2A), suggesting that
reducing ATP levels is not required for AMA to inhibit autophagy.
On the other hand, the treatment of AMPK activator AICAR
induced autophagy in MEF cells as reported (Liang et al., 2007).
However, cotreatment of AICRA and AMA increased the ATP
level but did not rescue the inhibition of autophagy by AMA (Fig-
ure 2B). These results suggest that the inhibition of autophagy by
AMA may be disconnected from its effect on intracellular ATP.
Production of reactive oxygen species (ROS) has been sug-
gested to play an important role in the induction of autophagy1476 Chemistry & Biology 18, 1474–1481, November 23, 2011 ª2011(Lipinski et al., 2010; Scherz-Shouval and Elazar, 2007;
Scherz-Shouval et al., 2007). Therefore, we tested the effect of
AMA on intracellular levels of ROS using dihydroethidium
(DHE) as a probe. Our results showed that the treatment of
AMA had no obvious effect on ROS in H4 and MEF cells under
the conditions that inhibit autophagy (Figure 2C). At higher con-
centrations, AMA increased ROS in H4 cells and decreased ROS
in MEF cells (Figures S2F and S2I). Because AMA inhibited auto-
phagy in both H4 and MEF cells (Figures 1B and 1C), AMA inhi-
bition of autophagy was unlikely to be caused by ROS reduction.
The loss of DJm has been reported to induce autophagy
(mitophagy) (Elmore et al., 2001). Thus, it is unlikely that AMA
should inhibit autophagy by reducing mitochondrial DJm.
Specifically, FCCP, an uncoupling agent that dissipates the
proton gradient across mitochondrial inner membrane to abolish
DJm (Gottlieb et al., 2000), has been reported to induce auto-
phagy in reticulocytes (Sandoval et al., 2008). To confirm this
result, we tested the effect of FCCP on autophagy. Our results
showed that the treatment of FCCP increased LC3-GFP+ puncta
in H4-LC3-GFP cells (Figure S2A), and induced LC3II increase in
H4 and MEF cells (Figure S2B). This evidence supports our
hypothesis that AMA inhibition of autophagy is not mediated
through DJm reduction.
mETC Complex III Is Required for AMA to Inhibit
Autophagy
Wepostulate that AMA inhibition of autophagymaydependon its
known bioactivity on mETC. To test this hypothesis, we carried
out a structural and functional analysis of AMA analogs to
examine if their activity on mitochondrial respiration may be
required for them to inhibit autophagy. Studies with a number of
derivatives and synthetic analogs showed that the dilactone
ring and the phenolic hydroxyl group are indispensable for the
activity of AMA on its respiration (Batra et al., 1971). Wemodified
an ester group on AMA dilactone ring to acylamide (AA01), or
methylated phenolic hydroxyl group (MeO-AA). The two
compounds are closely related to AMA in structure but cannot
inhibit mitochondrial respiration as measured by their effects on
the levels of ATP even at 10 mM (data not shown), whereas AMA
reduced the intracellular levels of ATP to about 30% at about
19 nM in MEF cells (Figure 2A). Other mitochondrially inactive
analogs, including AA01, MeO-AA, AA02, and AA10, also had
no effect on autophagy in MEF cells after treatment for 6 hr at
5 mM (Figure 3A), which is 500-fold more than the required
concentrationofAMA for inhibitingautophagy (10nM).Because
these close derivatives of AMA had no effect on mitochondrial
respiration or autophagy, we suggest that AMA inhibition of
autophagy may depend on its inhibition on mETC complex III.
To further test the role of mETC complex III on autophagy, we
used myxothiazol, another mETC complex III inhibitor. The
results showed that similar to that of AMA, the treatment of
myxothiazol also inhibited LC3-GFP+ spot counts in H4-LC3-
GFP cells (Figure 3B), and reduced the levels of LC3II in both
H4 and MEF cells (Figure 3C). Myxothiazol-mediated inhibition
of autophagy is also ROS and ATP independent because the
treatment of myxothiazol increased ROS in H4 cells (Figure 3D),
and decreased ATP to a level lower than that of glycolytic inhib-
itor 2DG (Figures 3D and 2A), which does not have any effect on
the levels of LC3II.Elsevier Ltd All rights reserved
Figure 3. mETC Complex III Is Required for AMA to Inhibit
Autophagy
(A) The structure of AMA and its analogs and the effects of AMA analogs on
autophagy. MEF cells were treated with AMA analogs in the presence or
absence of Rap (0.2 mM) for 6 hr at 5 mM, and the cell lysates were subjected to
western blotting using anti-LC3 and anti-a-tubulin antibodies.
(B) The effect of myxothiazol (Myxo) on autophagy. H4-LC3-GFP cells were
treated with Myxo at different concentrations in the presence or absence of
Rap (0.2 mM) as indicated for 4 hr, and the imageswere collected and analyzed
with a HCS Reader.
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Chemistry & Biology 18, 1474–148To further test the role of mitochondria, we examined the
effects of AMA and myxothiazol in mtDNA-depleted cells. Treat-
ment of cultured vertebrate cells with low amounts of EB results
in rapid and selective depletion of mtDNA (King and Attardi,
1989, 1996). We established mtDNA-depleted HeLa and H4
cell lines after EB (50 ng/ml) treatment for 12 days. Cytochrome
b, a mitochondrial marker, was not detectable in mtDNA-
depleted cells as assessed by western blotting, suggesting the
success of depleting mtDNA (Figure 3Ea). The levels of LC3II
were increased by rapamycin treatment in mtDNA-depleted
HeLa and mtDNA-depleted H4 cells, indicating that the auto-
phagy pathway was intact in mtDNA-depleted cells (Figure 3Ec).
However, neither AMA nor myxothiazol can inhibit the basal or
rapamycin-stimulated LC3II after mtDNA depletion (Figure 3Ec).
In contrast, AMA and myxothiazol obviously reduced the levels
of the basal as well as rapamycin-stimulated LC3II in normal
control HeLa and H4 cells (Figure 3Eb).
AMA showed no toxicity at the concentrations required for
inhibiting autophagy. There was no apparent cell death of MEF
or H4 cells exposed to 10 ng/ml AMA for more than 40 hr, and
cell growth was only slightly inhibited after 24 hr incubation
with AMA (Figures S1B and S1C). In fact AMA inhibits autophagy
inMEF cells at 5 ng/ml. These results suggest that AMA inhibition
of autophagy is not caused by cell death.
These results further support our hypothesis that the inhibition
of mETC complex III leads to inhibition of autophagy. Finally, we
attempted to examine the involvement of the complex I, II, and IV
using inhibitors of other mETC complexes (complex I, II, IV). After
treatment for 4 hr with rotenone, TTFA, or sodium azide (NaN3),
LC3II was reduced in MEF cells (Figure S2C). Conversely, rote-
none enhanced autophagy in H4 cells after treatment for 4 hr,
and TTFA and NaN3 had no obvious effect on the levels of
LC3II (Figure S2D). Under the conditions used for autophagy,
the complex I, II, and IV inhibitors affected parameters of mito-
chondrial function (MMP, ROS, or ATP) in both H4 andMEF cells
(Figure S2). Thus, unlike that of the complex III, the inhibitors
of mETC complex I, II, IV do not provide a consistent effect on
autophagy. Further studies are needed to address the roles of
the complexes I, II, and IV in autophagy.DISCUSSION
In this manuscript we show that AMA, a mETC complex III inhib-
itor, inhibits the basal and induced autophagy in normal cells.(C) H4 or MEF cells were treated with Myxo in the presence or absence of Rap
(0.2 mM) as indicated for 4 hr, and the cell lysates were subjected to western
blotting using anti-LC3 and anti-a-tubulin antibodies.
(D) H4 or MEF cells were treated with Myxo at indicated concentrations for 4 hr
and analyzed with ROS or ATP assay.
(E) The effects of AMA and Myxo in normal HeLa and normal H4 cells and
mtDNA-depleted HeLa and mtDNA-depleted H4 cells. (a) Parent H4 cells
and HeLa cells were cultured in the presence of EB (50 ng/ml), pyruvate
(100 mg/ml), and uridine (50 mg/ml) for 12 days. Both parent and EB-treated cell
lysates were subjected to western blotting using anti-cytochrome b and
anti-a-tubulin antibodies. (b and c) Normal HeLa and normal H4 cells (b),
mtDNA-depleted HeLa cells, andmtDNA-depleted H4 cells (c) were treated by
indicated compounds for 4 hr, and the cell lysates were subjected to western
blotting using anti-LC3 and anti-a-tubulin antibodies.
See also Figure S2.
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Figure 4. AMA Does Not Reactivate Class I PI3K-Akt-mTOR Signal
Pathway
MEF cells were treated for 6 hr with AMA at different concentrations as indi-
cated, and the cell lysates were subjected to western blotting using indicated
antibodies.
Chemistry & Biology
Antimycin A Inhibits AutophagyThis effect requires a functional mitochondrial respiration chain
because AMA has no effect in mtDNA-depleted cells. Addition-
ally, AMA analogs that do not inhibit mitochondrial respiratory
chain cannot inhibit autophagy even at 500-fold excess of
AMA concentration required for it to inhibit autophagy. Another
mETC complex III inhibitor myxothiazol with a structure unre-
lated to that of AMA also inhibits autophagy. These results
suggest that the mETC complex III may play a specific role in
autophagy regulation. Furthermore, because AMA shows inhibi-
tion of autophagy at a dose of 5 ng/ml, which has a minimum
effect on the cellular levels of ATP, a significant reduction in
the cellular levels of ATP is not required for AMA to inhibit
autophagy. On the other hand, because autophagy serves as
a recycling mechanism for energy and biomaterial under stress
conditions, inhibition of autophagy by AMA may contribute to
its effect on ATP. In addition, AMA has no obvious effect on
MMP and ROS under the conditions that inhibit autophagy,
which indicates that partial inhibition of complex III is enough
for inhibition of autophagy.
We used AMA as a tool to explore the mechanism of mETC
complex III in autophagy induction. We found that the treatment
of AMA reduced the levels of LC3II but had no effect on known
regulators of the pathway, such as the class I PI3K/Akt/mTORprecipitated from the lysates with a monoclonal antibody. The immunoprecip
anti-hVps34 antibodies.
(D) H4 cells were treated by AMA at 1 or 10 ng/ml for 4 hr, and the cell lysates w
1478 Chemistry & Biology 18, 1474–1481, November 23, 2011 ª2011signal transduction pathway (Figure 4), the levels of proteins in
class III PI3K complex including Vps34 and Beclin1, and also
Atg12-Atg5 conjugate (Figure 5).
How might the mitochondrial complex III be involved in auto-
phagosome initiation? One possibility is that the complex III
regulates a signaling event in autophagy. The complex III has
been proposed to regulate the activity of HIF (Guzy et al.,
2005; Tormos and Chandel, 2010), and because HIF-1 has
been shown to regulate the expression of BNIP3, which in turn
promotes autophagy, future experiments could examine the
possibility for the involvement of HIF-1 and BNIP3 in AMA-medi-
ated autophagy inhibition. Another possibility is the source of
autophagic membrane. Mitochondria have been suggested
to donate lipids to autophagic membrane in mammalian cells
(Hailey et al., 2010). The membranes of isolation membrane
and autophagosomes are of the thin type (6–7 nm), like themem-
branes of the endoplasmic reticulum (ER), cis-Golgi, nuclear
envelope, and the inner and outer membranes of mitochondria.
It is possible that different membrane pools may contribute to
the isolation membrane (Juhasz and Neufeld, 2006; Reggiori
and Klionsky, 2005). It has not been demonstrated whether mito-
chondria have provided lipids for autophagic membranes in
mammalian cells, except starvation-induced autophagy (Hailey
et al., 2010). Recently, ER and Golgi have been suggested as
the origin of autophagosomal membranes in mammalian cells
(Axe et al., 2008; Geng et al., 2010; Hayashi-Nishino et al.,
2009; Takahashi et al., 2011; van der Vaart et al., 2010; van der
Vaart and Reggiori, 2010; Yla¨-Anttila et al., 2009), but the
detailed mechanism is unknown. However, no evidence indi-
cates that ER or Golgi is the only origin for autophagic
membranes in mammalian cells.
The outer membrane of mitochondria in mammalian cells has
been suggested as a new source of autophagosomal mem-
branes under starvation conditions (Hailey et al., 2010; McEwan
and Dikic, 2010). Mitochondria may also supply lipids for auto-
phagosomalmembraneswith a different mechanism under other
conditions. Whether or not mitochondria in mammalian cells
contribute to the autophagic membrane under other conditions
except starvation remains to be seen. We propose that AMA
and other complex III inhibitors might provide a tool for such
studies.Figure 5. AMA Has No Effect on Class III
PI3K (hVps34), Beclin1 Protein Levels and
Their Complex, and Atg12-Atg5 Conjugate
System
(A and B) The effect of AMA on the levels of hVps34
and Beclin1 proteins. MEF cells were treated with
AMA for 6 hr at different concentrations (A) or with
AMA at 10 ng/ml in the presence or absence of
rapamycin (Rap) for different times as indicated
(B), and the cell lysates were subjected to western
blotting using anti-Beclin1, anti-hVps34, and anti-
a-tubulin antibodies.
(C) The effect of AMA on endogenous hVps34/
Beclin1 complex. MEF cells were treated by indi-
cated compounds for 4 hr. Beclin1 was immuno-
itates were subjected to western blotting using polyclonal anti-Beclin1 and
ere subjected to western blotting using Atg12 and anti-a-tubulin antibodies.
Elsevier Ltd All rights reserved
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Autophagy is a cellular lysosome-dependent catabolic
mechanism mediating the turnover of intracellular organ-
elles and long-lived proteins. Dysfunction of autophagy
has been implicated in multiple human diseases. Identifica-
tion of autophagy factors in mammalian cells is important to
understand how this complex cellular pathway responds to
a broad range of challenges. Here, we report that mitochon-
drial electron transport chain (mETC) complex III plays a role
in autophagy induction. We show that antimycin A, a known
inhibitor of mETC complex III, can inhibit both rapamycin
and serum starvation-induced autophagy. A structural and
functional study shows that four close analogs of antimycin
A that have no effect on mitochondria inhibition also do not
inhibit autophagy, whereas myxothiazol, another mETC
complex III inhibitor with unrelated structure to antimycin
A, inhibits autophagy. Additionally, antimycin A and myxo-
thiazol cannot inhibit autophagy in mtDNA-depleted H4
and mtDNA-depleted HeLa cells. These data suggest that
antimycin A inhibits autophagy through its inhibitory activity
on mETC complex III. Our data suggest that mETC complex
III may have a role in mediating autophagy induction. Two
mechanisms are supposed for mitochondrial complex III in
regulating autophagosome initiation. One possibility is that
the complex III regulates a signaling event in autophagy.
The complex III has been proposed to regulate the activity
of HIF, and because HIF-1 has been shown to regulate the
expression of BNIP3, which in turn promotes autophagy,
future experiments could examine the possibility for the
involvement of HIF-1 and BNIP3 in AMA-mediated auto-
phagy inhibition. Another possibility is the involvement of
mitochondria as a source of autophagic membrane. Mito-
chondria have been suggested to donate lipids to autopha-
gic membrane. Whether mitochondria in mammalian cells
contribute to the autophagic membrane under normal nutri-
tional conditions remains to be seen. We propose that AMA
and other complex III inhibitors might provide a tool for such
studies.EXPERIMENTAL PROCEDURES
Plasmids, Antibodies, Cell Reagents, and Cell Lines
The following compoundswere used: rapamycin (Sigma-Aldrich; R0395); AMA
(Sigma-Aldrich; A8674); rotenone (Sigma-Aldrich; R8875); TTFA (Sigma-
Aldrich; T27006); MG132 (Sigma-Aldrich; C2211); E-64d (Sigma-Aldrich;
E8640); 2DG (Sigma-Aldrich; D8375); AICAR (Sigma-Aldrich; A9978); and
DHE (Sigma-Aldrich; D7008). AMA derivatives were provided by Professor
Dawei Ma. NaN3 was from AMRESCO (0639). GFP-LC3-expressing con-
structs were as previously described (Shibata et al., 2006). ATP biolumines-
cent assay kit was from Promega (V6713). Monoclonal anti-a-tubulin was
from Sigma-Aldrich (T6074). Polyclonal anti-LC3 was from Sigma-Aldrich
(L7543) or Novus (NB600-1384). HRP-conjugated goat anti-mouse IgG anti-
body and HRP-conjugated goat anti-rabbit IgG antibody were from Chemicon
(AP307P, AP308P). H4 and HeLa cell lines were the same as previously
described (Pan et al., 2008).
Cell Culture and Transfection
The cells used for the experiments were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum,
100 U/ml penicillin/streptomycin, and 2 mM L-glutamine at 37C, 5% CO2.Chemistry & Biology 18, 1474–148Transfection of H4 cells was done using Lipofectamine 2000 reagent
(Invitrogen; 18324-012). For starvation, cells were washed with phosphate-
buffered saline (PBS) and incubated in serum-free DMEM. MtDNA-depleted
H4 and mtDNA-depleted HeLa cells were established as follows: parental
H4 cells and HeLa cells were cultured in the presence of EB (50 ng/ml), pyru-
vate (100 mg/ml), and uridine (50 mg/ml). After 12 days, EB treatment cells were
grown in the same medium without EB, and mtDNA-depleted cell lines were
established.
Image Analysis
H4-LC3-GFP cells were seeded in 96-well plate and cultured in the presence
of compounds for the time as indicated. Images data were collected and
analyzed with a Thermo Scientific ArrayScan VTI HCS Reader. DMSO and
rapamycin were used as negative or positive control, respectively. GFP-
LC3-labeled vacuoles are denoted as dots in all figures.
Immunoprecipitation and Immunoblotting
Cell lysates were prepared in a lysis buffer (50 mM Tris-HCl [pH 7.5], 150 mM
NaCl, 1 mM EDTA, and 1% Triton X-100, 1 mM phenylmethanesulfonyl
fluoride, 1 mM Na3VO4, and protease inhibitor cocktail). The lysates were
clarified by centrifugation at 14,000 rpm for 15 min and were subjected to
immunoprecipitation using specific antibodies in combination with protein
G-agarose (Invitrogen). Precipitated immunocomplexes were washed four
times in wash buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA,
and 1%Triton X-100) and boiled in sample buffer. Samples were subsequently
separated by SDS-PAGE and transferred to Immobilon-P polyvinylidene
difluoride membranes (Millipore). Immunoblotting analysis was performed
with indicated antibodies and visualized with SuperSignal West Pico Chemilu-
minescent Substrate (Pierce Chemical).
ATP and ROS Assays
ATP was measured using a luciferin-luciferase assay kit (Promega) by
following the manufacturer’s instruction. The levels of intracellular ROS were
measured by using a fluorescence probe DHE. The cells were treated with
AMA for 2 hr and then incubated with 1 mg/ml DHE at 37C for 20 min in
HBSS. Fluorescent images were collected and analyzed with Thermo Scien-
tific ArrayScan VTI HCS Reader.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and two figures and can be found with this article online at doi:10.1016/
j.chembiol.2011.08.009.
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